Fig. 3From: Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-upa, b, c Overall survival (OS) (a), local progression-free survival (LPFS) (b), metastasis-free survival (MFS) (c). OS was calculated according to the Kaplan-Meier method as the time from diagnosis until death or last recorded follow-up. Pts = patientsBack to article page